Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03877497 · ClinicalTrials.gov registry record · NA

To Reach Unrestricted Services for Transgender Women

A NA study of HIV and Substance Abuse, sponsored by University of Central Florida.

Completed
Registry status
NA
Development phase
86
Enrollment target
2
Study locations

NCT03877497 is a NA study of HIV and Substance Abuse that has completed, run by University of Central Florida. The registered enrollment target is 86 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03877497, a NA study of HIV and Substance Abuse, has completed, sponsored by University of Central Florida.

COMPLETED
Registry status
NA
Development phase
86 participants
Enrollment target
2
Study locations

Study Summary

Florida has the fifth largest transgender population in the United States. Transgender women, particularly those of color, in the southern part of Florida are a marginalized population who are impacted by co-morbidities of substance abuse and HIV in their communities. The overall objective of the study is to use a vetted adapted brief intervention to stem the development of substance abuse in at-risk transgender women, and thereby increase primary and secondary prevention methods such as routine HIV screening, uptake of pre-exposure prophylaxis (PrEP) and use of non-occupational post-exposure prophylaxis (nPEP).

Interventions

  • BEHAVIORAL Adapted SBIRT-T for transgender women

Study Locations (2)

Florida

  • Florida International University - Miami
  • University of Central Florida - Orlando

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2019-09-19
Est. Completion 2024-12-04
Phase NA

Sponsor

University of Central Florida

91 total trials

What the Registry Record Tells You About NCT03877497

The ClinicalTrials.gov registry entry for NCT03877497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower). The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Adapted SBIRT-T for transgender women is the first listed.

NCT03877497 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03877497 about?

NCT03877497 is a clinical study titled "To Reach Unrestricted Services for Transgender Women". Florida has the fifth largest transgender population in the United States. Transgender women, particularly those of color, in the southern part of Florida are a marginalized population who are impacted by co-morbidities of substance abuse and HIV in their communities. The overall objective of the st...

What is the current status of trial NCT03877497?

This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2019-09-19. Estimated completion is 2024-12-04.

What conditions does trial NCT03877497 study?

This clinical trial studies the following conditions: HIV, Substance Abuse, Transgender Women.

What interventions are being tested in trial NCT03877497?

The interventions under investigation include: Adapted SBIRT-T for transgender women (BEHAVIORAL).

Who is sponsoring clinical trial NCT03877497?

This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03877497 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.